Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biocon Ltd. Regulatory Filings 2021

Mar 9, 2021

61176_rns_2021-03-09_34f5a837-a20d-421a-ab27-8fdea8c13606.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [139 x 54] intentionally omitted <==

Biocon Limited 20th KM Hosur Road Electronics City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA 1978PLC003417

March 09, 2021

www.biocon.com

, www.biocon.com
To To
The Secretary The Secretary
BSE Limited National Stock Exchange of India Limited
Department of Corporate Services Corporate Communication Department
Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex
Dalal Street,Mumbai - 400 001 Mumbai - 400 050
Scrip Code - 532523 Scrip Symbol - BIOCON

Dear Sir/Madam,

Sub: Meeting conducted with Institutional Investors/Research Analysts.

Ref: Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that the following meeting was conducted with Institutional Investor / Research Analysts:

Date Name Type of meeting Location
March 09,2021 Akash Ganga Investments Teleconference Bangalore

We request you to kindly take above intimation on record.

Thanking You,

==> picture [89 x 87] intentionally omitted <==

Yours faithfully,

For Biocon Limited

==> picture [59 x 33] intentionally omitted <==

----- Start of picture text -----

�-
----- End of picture text -----

  • ~~Mayank Verma~~ Company Secretary and Compliance Officer